Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations

Activists protest the price of prescription drug costs in front of the U.S. Department of Health…

Healthy Returns: Eli Lilly gains momentum against Novo Nordisk in the weight loss drug market

An Eli Lilly & Co. Zepbound injection pen, March 28, 2024. Bloomberg | Bloomberg | Getty…

Digital health company Ro launches GLP-1 insurance-coverage checker to help patients navigate costs

Zoom In IconArrows pointing outwards The direct-to-consumer health-care startup Ro launched a new free tool Tuesday…

Eli Lilly blows past estimates, hikes guidance as Zepbound, Mounjaro sales soar

Eli Lilly on Thursday reported second-quarter earnings and revenue that blew past expectations and hiked its…

Eli Lilly reports earnings Thursday. Here’s what Wall Street is watching

Investors want to know whether Eli Lilly is seeing the same pricing pressures on its blockbuster…

CVS slashes profit guidance, will cut $2 billion in expenses as insurance costs climb

The CVS pharmacy logo is displayed on a sign above a CVS Health Corp. store in…

Healthy Returns: What drugmakers are saying about final negotiated prices with Medicare

President Joe Biden speaks during an event at the National Institutes of Health in Bethesda, Maryland,…

Eli Lilly’s Zepbound and Mounjaro now available in U.S. after shortages, FDA says

An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City…

Eli Lilly’s weight loss drug Zepbound cuts heart failure risks in late-stage study

An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York,…

Biogen beats expectations, hikes outlook as Alzheimer’s drug Leqembi and other new products gain traction

A test tube is seen in front of displayed Biogen logo in this illustration taken on,…

Moderna beats estimates but slashes guidance on low EU sales, competitive U.S. vaccine market

Moderna on Thursday reported second-quarter revenue that beat expectations but slashed its full-year sales guidance, citing…

Healthy Returns: Here’s what GLP-1s are being tested for beyond weight loss, diabetes

Weight loss syringes of the brands “Wegovy”, “Ozempic” and “Mounjaro” are sold at In der Achat…

Patients on Alzheimer’s drug Leqembi see benefits over three years, Eisai study says

The newly FDA approved Alzheimer’s treatment Leqembi is prepared at Abington Neurological Associates in Abington, PA.,…

Merck shares fall 9% despite earnings beat, strong demand for top drugs like Keytruda

The exterior view of the entrance to Merck headquarters in Rahway, New Jersey, on Feb. 5,…

Pfizer beats earnings estimates, hikes full-year outlook as drugmaker cuts costs

Kena Betancur | Corbis News | Getty Images Pfizer on Tuesday reported second-quarter revenue and adjusted earnings…

Newseum Global